1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES HAVING EFFECTS OF PREVENTING AND TREATING DEGENERATIVE AND INFLAMMATORY DISEASES
    1.
    发明申请
    1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES HAVING EFFECTS OF PREVENTING AND TREATING DEGENERATIVE AND INFLAMMATORY DISEASES 审中-公开
    具有预防和治疗衰老和炎症疾病的作用的1,2,3,4-四氢喹啉衍生物

    公开(公告)号:US20100217003A1

    公开(公告)日:2010-08-26

    申请号:US12518068

    申请日:2007-12-10

    IPC分类号: C07D217/04

    CPC分类号: A61K31/472

    摘要: Provided are 7-hydroxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline derivatives and synthesis methods thereof. The compounds significantly inhibit the production of nitrogen monoxide (NO) and superoxide in an activated microglial cell and expressions of TNF-α, IL-1β inducive NO synthase and cyclooxygenase-2 genes. They also prevent NF-kB shift to a nucleus, decrease reactive oxygen species (ROS), inhibit expression of GTP cyclohydrolase I gene and over-production of tetrahydrobiopterin (BH4), and protect dopaminergic neurons from injury due to activated microglial cells. Consequently, the compounds are effective in treating inflammatory and neurodegenerative diseases.

    摘要翻译: 提供7-羟基-6-甲氧基-1,2,3,4-四氢异喹啉衍生物及其合成方法。 该化合物显着抑制活化的小胶质细胞中一氧化氮(NO)和超氧化物的产生以及TNF-α,IL-1和bgr的表达。 诱导性NO合成酶和环氧合酶-2基因。 它们还可以阻止NF-kB转移到细胞核,减少活性氧(ROS),抑制GTP环化水解酶I基因的表达和四氢生物喋呤(BH4)的过量产生,并保护多巴胺能神经元免受活化的小胶质细胞的损伤。 因此,这些化合物有效地治疗炎性和神经退行性疾病。

    NANOPARTICLE SENSOR FOR MEASURING PROTEASE ACTIVITY AND METHOD FOR MANUFACTURING THE SAME
    3.
    发明申请
    NANOPARTICLE SENSOR FOR MEASURING PROTEASE ACTIVITY AND METHOD FOR MANUFACTURING THE SAME 有权
    用于测量蛋白酶活性的纳米颗粒传感器及其制造方法

    公开(公告)号:US20110213121A1

    公开(公告)日:2011-09-01

    申请号:US13060902

    申请日:2009-08-27

    IPC分类号: C07K9/00 B82Y5/00

    摘要: Disclosed are a nanoparticle sensor for measuring protease activity, for protease imaging, and a method for preparing the same. More specifically, the present invention relates to a nanoparticle sensor for measuring protease activity in which a fluorophore- and a quencher-conjugated peptide substrate is conjugated to a biocompatible polymer nanoparticle. The peptide substrate is specifically lysed by a protease. The sensor according to the present invention is capable of inhibiting emission of fluorescence with high extinctive activity of the quencher on a fluorescent material. But strong fluorescence is specifically emitted only if the peptide substrate is lysed by a specific protease. Therefore, the sensor is especially useful as a method for screening a novel drug such as a protease overexpression inhibitor, and early diagnosis of incurable diseases and various diseases such as autoimmune diseases including cancer, osteoarthritis, rheumatoid arthritis and dementia.

    摘要翻译: 公开了用于测定蛋白酶活性的蛋白酶成像用纳米粒子传感器及其制备方法。 更具体地,本发明涉及用于测量蛋白酶活性的纳米颗粒传感器,其中荧光团和猝灭剂缀合的肽底物与生物相容性聚合物纳米颗粒缀合。 肽底物被蛋白酶特异性裂解。 根据本发明的传感器能​​够抑制荧光材料上猝灭剂具有高灭绝活性的荧光发射。 但是如果肽底物被特异性蛋白酶裂解,则强荧光是特异性发射的。 因此,该传感器作为筛选新型药物如蛋白酶过表达抑制剂的方法,以及早期诊断不治之症以及各种疾病,如自身免疫性疾病,包括癌症,骨关节炎,类风湿性关节炎和痴呆症,都是特别有用的。

    Apparatus and method for synthesizing F-18 labeled radioactive pharmaceuticals
    5.
    发明授权
    Apparatus and method for synthesizing F-18 labeled radioactive pharmaceuticals 有权
    用于合成F-18标记的放射性药物的装置和方法

    公开(公告)号:US09254471B2

    公开(公告)日:2016-02-09

    申请号:US14117622

    申请日:2012-05-11

    摘要: Method and apparatus for synthesizing an F-18 labeled radioactive pharmaceutical by labeling a precursor with an F-18 radioactive isotope, by reacting the labeled precursor to obtain a labeled pharmaceutical, by separating impurities from the labeled pharmaceutical to provide a purified labeled pharmaceutical, and by collecting the purified labeled pharmaceutical. The apparatus includes a labeling cartridge that contains the precursor, receives the isotope, and causes a labeling reaction to provide the labeled precursor; a synthesizing container that receives the labeled precursor, receives at least one reagent effective to hydrolyze the labeled precursor, and within which the labeled precursor undergoes a hydrolysis reaction to provide the labeled pharmaceutical; and a separation cartridge that receives the labeled pharmaceutical, and contains a polymer compound that separates impurities into polar compounds and nonpolar compounds to provide the purified labeled pharmaceutical. The labeling and separation cartridges may be contained in a removable cassette.

    摘要翻译: 通过用F-18放射性同位素标记前体,通过使标记的前体反应得到标记的药物,通过从标记药物中分离杂质以提供纯化的标记药物,合成F-18标记的放射性药物的方法和装置,以及 通过收集纯化的标记药物。 该装置包括含有前体的标记盒,接受同位素,并引起标记反应以提供标记的前体; 接收标记的前体的合成容器接收至少一种有效水解标记的前体的试剂,并且其中标记的前体经历水解反应以提供标记的药物; 以及接收标记药物的分离盒,并且含有将杂质分离成极性化合物和非极性化合物以提供纯化的标记药物的高分子化合物。 标签和分离盒可以包含在可拆卸的盒中。